TORNTPHARM.NS Balance Sheet
Torrent Pharmaceuticals Ltd.
Profit & Loss Balance Sheet Cash Flow
Balance Sheet · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-24 00:34
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Property, Plant and Equipment | ₹27.72 Bn | ₹32.97 Bn | ₹34.55 Bn | ₹49.09 Bn | PropertyPlantAndEquipment |
| Capital Work-in-Progress | ₹6.88 Bn | ₹2.81 Bn | ₹3.67 Bn | ₹4.57 Bn | CapitalWorkInProgress |
| Goodwill | ₹3.38 Bn | ₹3.38 Bn | ₹3.39 Bn | ₹39.90 Bn | Goodwill |
| Other Intangible Assets | ₹50.12 Bn | ₹45.03 Bn | ₹41.52 Bn | ₹242.80 Bn | OtherIntangibleAssets |
| Non-current Investments | ₹0.43 Bn | ₹0.32 Bn | ₹0.44 Bn | ₹0.83 Bn | NoncurrentInvestments |
| Other Non-current Assets | ₹1.58 Bn | ₹3.24 Bn | ₹2.68 Bn | ₹2.58 Bn | OtherNoncurrentAssets |
| Total Non-current Assets | ₹96.83 Bn | ₹94.50 Bn | ₹93.67 Bn | ₹349.19 Bn | NoncurrentAssets |
| Inventories | ₹22.30 Bn | ₹22.79 Bn | ₹25.41 Bn | ₹31.38 Bn | Inventories |
| Trade Receivables | ₹19.44 Bn | ₹18.44 Bn | ₹18.67 Bn | ₹30.31 Bn | TradeReceivablesCurrent |
| Cash and Cash Equivalents | ₹5.08 Bn | ₹8.35 Bn | ₹5.73 Bn | ₹11.17 Bn | CashAndCashEquivalents |
| Current Investments | ₹1.56 Bn | ₹1.41 Bn | ₹1.12 Bn | ₹8.66 Bn | CurrentInvestments |
| Other Current Assets | ₹3.03 Bn | ₹3.04 Bn | ₹3.36 Bn | ₹6.29 Bn | OtherCurrentAssets |
| Total Current Assets | ₹53.14 Bn | ₹56.11 Bn | ₹56.23 Bn | ₹93.92 Bn | CurrentAssets |
| Total Assets | ₹150.12 Bn | ₹150.61 Bn | ₹149.90 Bn | ₹443.12 Bn | Assets |
| Equity Share Capital | ₹1.69 Bn | ₹1.69 Bn | ₹1.69 Bn | ₹1.69 Bn | EquityShareCapital |
| Other Equity | ₹60.29 Bn | ₹66.87 Bn | ₹74.22 Bn | ₹82.20 Bn | OtherEquity |
| Equity Attributable to Owners | ₹61.98 Bn | ₹68.56 Bn | ₹75.91 Bn | ₹83.89 Bn | EquityAttributableToOwnersOfParent |
| Non-controlling Interests | ₹0.00 Bn | N/A | ₹0.00 Bn | ₹91.96 Bn | NonControllingInterest |
| Total Equity | ₹61.98 Bn | ₹68.56 Bn | ₹75.91 Bn | ₹175.85 Bn | Equity |
| Long-term Borrowings | ₹24.96 Bn | ₹16.04 Bn | ₹11.92 Bn | ₹116.51 Bn | BorrowingsNoncurrent |
| Total Non-current Liabilities | ₹33.67 Bn | ₹27.79 Bn | ₹26.82 Bn | ₹183.84 Bn | NoncurrentLiabilities |
| Short-term Borrowings | ₹28.01 Bn | ₹23.34 Bn | ₹18.34 Bn | ₹31.47 Bn | BorrowingsCurrent |
| Trade Payables | ₹16.79 Bn | ₹20.89 Bn | ₹18.20 Bn | ₹23.58 Bn | TradePayablesCurrent |
| Other Current Liabilities | ₹1.03 Bn | ₹1.30 Bn | ₹1.36 Bn | ₹1.76 Bn | OtherCurrentLiabilities |
| Total Current Liabilities | ₹54.47 Bn | ₹54.26 Bn | ₹47.17 Bn | ₹83.43 Bn | CurrentLiabilities |
| Total Equity and Liabilities | ₹150.12 Bn | ₹150.61 Bn | ₹149.90 Bn | ₹443.12 Bn | EquityAndLiabilities |
Every figure above is the exact value of the named XBRL element from TORNTPHARM.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).